Navigation Links
Why 'event cloaks' could be the key to the ultimate bank heist

In this month's special issue of Physics World, which examines the science and applications of invisibility, Martin McCall and Paul Kinsler of Imperial College London describe a new type of invisibility cloak that does not just hide objects but events.

Using the ultimate bank heist as an example, McCall and Kinsler explain how a thief could, in principle, use an "event cloak" to steal money from a safe, without even the CCTV surveillance cameras being aware.

The burglar would somehow need to split all the light approaching the safe into two parts: "before" and "after", with the "before" part sped up and the "after" part slowed down.

This would create a brief period of darkness during which the burglar could enter the scene and steal the money, being careful to close the safe door before they leave.

With the safe-cracker gone, the process of speeding up and slowing down the light would then be reversed, leading to an apparently untouched scene once again.

Robbing a bank is, of course, only an example to illustrate the principle of what an event cloak could do. As McCall and Kinsler explain, a more likely application of a full-size event cloak would be to control the flow of signals in an optical routing system, where one may need to process simultaneous uninterrupted signals at the same time.

For these aspirations to become a reality, suitable materials need to be developed that can manipulate the light to speed it up or slow it down. The consensus seems to be that a set of parallel, artificially structured "metamaterial" layers would be needed, each containing an array of tiny metallic elements that can be controlled to dynamically adjust the speed of light passing through.

If a high-performance, macroscopic-size, fully functional spacetime cloak could be developed, one potential "party trick" could be a Star Trek-type transporter, in which a person could appear to instantly relocate from one point to another.

Although no-one has yet tried to build a spacetime cloak in the lab, McCall and Kinsler argue that "there is no obvious reason why such a cloak could not be achieved quite soon, perhaps even within a few years".

Also in this month's special issue on invisibility.

  • Invisibility is now a reality, but scientists are not satisfied and are still searching for the holy grail a cloak of invisibility that can hide macroscale objects from view at any angle, using unpolarized visible light. Wenshan Cai and Vladimir Shalaev map out the road ahead on this mission.

  • The quest to achieve true invisibility has inspired ambitious goals beyond merely cloaking visible light. Ulf Leonhardt takes a light-hearted look at the top five possible spin-offs from invisibility science.

  • Tales of invisible people and magical invisibility-bestowing objects have thrilled us for millennia. Sidney Perkowitz reveals how these myths and fantasies are now becoming a reality.


Contact: Michael Bishop
Institute of Physics

Related biology technology :

1. Amgen Submits Application to Expand Indication for XGEVA® (Denosumab) to Prevent or Delay Spread of Prostate Cancer to the Bone
2. New Jersey Targets Life-Sciences Investors at Worlds Largest Biotechnology Event
3. Verizon to Invest $125,000 to Support Domestic Violence Outreach, Prevention, Education and Awareness Programs in Virginia
4. NeoStem to Present at Two Investor Events This Month
5. Researchers From More Than 30 Countries Share Findings About the Use of Ultrasound in the Prevention, Diagnosis and Treatment of Heart Disease
6. Hospital for Special Surgery to Host International Arthritis Summit: Frontiers in Osteoarthritis Research, Prevention and Care
7. LifeVantages Nrf2 Activator Reviewed for Tumor Prevention and Suppression in New Peer-Reviewed Article
8. Advantagene Announces SPA Agreement With FDA to Launch Phase 3 Trial for Novel Vaccine Aimed at Preventing Prostate Cancer Recurrence
9. Phase 3 Data Demonstrate XGEVA™ (Denosumab) is First Bone Targeted Therapy to Prevent Spread of Cancer to the Bone in Men With Advanced Prostate Cancer
10. MiMedx Group, Inc. to Present at the Noble Financial Capital Markets Seventh Annual Equity Conference
11. PharmacoFore, Inc. Announces Sponsorship of the 2011 CLAAD National Prescription Drug Abuse Prevention Policy Consensus Meeting on November 29, 2011 in Washington, DC
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... 23, 2016 Andrew ... Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
(Date:6/23/2016)... San Francisco, CA (PRWEB) , ... June 23, ... ... capture (EDC) software, is exhibiting at the Pennsylvania Convention Center and will showcase ... DIA Annual conference. ClinCapture will also be presenting a scientific poster on Disrupting ...
(Date:6/23/2016)... Connecticut (PRWEB) , ... June 23, 2016 , ... ... introduce a new line of intelligent tools designed, tuned and optimized exclusively for ... September 12–17 in Chicago. The result of a collaboration among several companies with ...
Breaking Biology Technology:
(Date:5/12/2016)... -- , a brand of Troubadour Research ... the Q1 wave of its quarterly wearables survey. A ... to a program where they would receive discounts for ... "We were surprised to see that so ... , CEO of Troubadour Research, "primarily because there are ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
Breaking Biology News(10 mins):